Robert Cubas, MD
Payments from drug & device makers
What this record shows
This record is dominated by grants: $15,000 of the $24,106 with a category attached, or 62.2%. Boston Scientific accounts for 70.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $7,826 and has fallen 58.9% since, to $3,220 in 2025.
Across 110 payments — averaging $219.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$17K
- Intuitive Surgical$3K
- Davol Inc.$1K
- Enterra Medical, Inc.$1K
- AbbVie$676
- Medtronic$208
- plus $743 from 8 others
What the payments were for
- Grants$15,00062%
- Travel & lodging$2,54111%
- Food & beverage$6,41327%
- Education$1431%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $16,881 |
| Intuitive Surgical | 50 | $2,861 |
| Davol Inc. | 19 | $1,440 |
| Enterra Medical, Inc. | 5 | $1,297 |
| AbbVie(2 entities) | 5 | $676 |
| Medtronic | 2 | $208 |
| KARL Storz Endoscopy-america | 2 | $156 |
| TELA Bio, Inc. | 1 | $151 |
| Philips North America LLC | 1 | $130 |
| Guard Medical Inc. | 1 | $100 |
| Integra Lifesciences Corporation | 2 | $70 |
| Novo Nordisk | 2 | $47 |
| Johnson & Johnson | 1 | $45 |
| Intra-sana Laboratories | 2 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - BILIARY DEVICES$15,000
- Da Vinci Surgical System$1,891
- OverStitch Endoscopic Suturing System$1,313
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$534
- Phasix Mesh$363
- Signia$174
- ARISTA AH FLEXITIP$167
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$151
- STRATTICE$143
- SpyGlass Discover$137
- (9124) LM Undivided$130
- NPseal$100
- NPSEAL MEDIUM$100
- NPSEAL LARGE$100
How this compares
$24,106 in reported general payments places this provider in the 85th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $72 |
| Metformin Hcl | 14 | $38 |
Paid to pharmacies, not to this prescriber.
Other surgery in Miami
- Anthony GonzalezMiami$686K
- Jose MartinezMiami$186K
- Michael RendaMiami$90K
- Jorge FlorinWinter Garden$2.2M
- Amit TaggarTampa$1.4M
- Keith KimCelebration$1.1M
- Richard DiciccoTampa$964K
- Elizabeth DovecLakeland$870K
- Christopher DucoinTampa$808K
- Andre TeixeiraOcala$731K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.